Streetbeat News

Partnerships

CMND

FLHLF

HUGE

MNMD

PBM

The article provides a comprehensive roundup of recent developments in the psychedelics field, including research findings, global regulatory perspectives, therapeutic applications, and business news. Key highlights include potential roles of psilocybin in dementia prevention and psychological flexibility, global legalization trends, and various companies' strategic moves such as voluntary delistings, partnership agreements, financial results, and patent filings related to psychedelic therapies.

Portfolio Pulse from Lara Goldstein

April 17, 2024 | 1:13 pm

BA

RYAAY

Ryanair Holdings plc (NASDAQ:RYAAY) shares are up in premarket trading as the company expects Boeing Co (NYSE:BA) to deliver 40 new jets by mid-July, according to CEO Michael O’Leary. This delivery schedule aligns with previous adjustments following delays. Ryanair had initially expected 57 Boeing MAX 8200 planes by the end of April but revised this number to 40 due to complications at Boeing. Despite these adjustments, Ryanair plans to resume flights to Tel Aviv on June 3, with ongoing vigilance regarding safety concerns.

Portfolio Pulse from Shivani Kumaresan

April 17, 2024 | 1:07 pm

ERIC

Nex-Tech Wireless has partnered with Ericsson (ERIC) to provide advanced connectivity solutions to communities in Kansas. This collaboration aims to enhance wireless infrastructure and bring cutting-edge technology to the region, improving access to high-speed internet and supporting local development.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 1:07 pm

ABVC

ABVC BioPharma, Inc. (NASDAQ:ABVC) has entered into a licensing agreement with OncoX for the development and commercialization of BLEX 404, a drug for treating Non-Small Cell Lung Cancer (NSCLC), derived from Maitake Mushroom. The agreement includes an upfront payment of $12.5 million in cash or shares, a milestone payment of $1.25 million, and royalties up to $12.5 million. This partnership aims to leverage ABVC's R&D capabilities and OncoX's market positioning to address the unmet needs in NSCLC treatment, potentially transforming patient outcomes with combination therapy.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 1:01 pm

INTA

Accordion, a financial consulting firm, has chosen Intapp DealCloud to boost its growth. This partnership aims to enhance Accordion's operational efficiency and client service capabilities, leveraging Intapp DealCloud's specialized software solutions for the financial services sector.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 1:01 pm

MCHI

Chinese exporters at the Canton Fair are facing challenges despite China's 5.3% economic growth in Q1, including a decline in exports and producer prices. Increased economic and political tensions with the U.S., global trade slowdowns, and manufacturing overcapacity are key issues. Some sectors, like high-tech, remain optimistic due to government support. Trade tensions could worsen with potential U.S. tariffs and blacklisting of Chinese companies. The iShares MSCI China ETF (MCHI) saw a 1.02% dip.

Portfolio Pulse from Benzinga Neuro

April 17, 2024 | 12:58 pm

PLTR

Palantir Technologies Inc. (NYSE:PLTR) shares are trading higher in the premarket session after the company announced it has been designated as an 'Awardable' vendor for the Chief Digital and Artificial Intelligence Office's (CDAO) Tradewinds Solutions Marketplace. This designation allows the Department of Defense to access two of Palantir's product offerings, including its AI Mission Command Capability and Predictive Maintenance & Precision Sustainment Suite, through the Marketplace to support critical missions.

Portfolio Pulse from Nabaparna Bhattacharya

April 17, 2024 | 12:52 pm

BA

UAL

United Airlines Holdings Inc (NASDAQ:UAL) shares rose after reporting Q1 results surpassing estimates with $12.539 billion in revenue and a loss of 15 cents per share. Capacity increased by 9.1% year-over-year, with slight improvements in TRASM and CASM. United ended the quarter with $16.9 billion in liquidity and adjusted its fleet plan, converting Boeing Max 10 orders to Max 9 and intending to lease 35 Airbus A321neos. The company reaffirmed its full-year 2024 earnings outlook.

Portfolio Pulse from Adam Eckert

April 17, 2024 | 12:50 pm

XPER

Xperi Inc. has issued a letter to its stockholders, urging them to vote for its five director nominees at the upcoming Annual Meeting on May 24, 2024. The letter highlights Xperi's transformation from a semiconductor IP licensing company to a consumer entertainment technology company, focusing on connected TV advertising, streaming television, and in-vehicle infotainment. Xperi's board and management have driven this change, notably through acquisitions like DTS and the merger with TiVo. The company has seen five consecutive quarters of year-over-year revenue growth and expects continued growth and margin expansion. Xperi is contesting Rubric Capital's campaign to replace two directors, arguing that Rubric's nominees lack relevant experience and could hinder the company's progress.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:35 pm

IGMS

SNY

IGM Biosciences has entered into a global collaboration agreement with Sanofi to create and develop IgM agonist antibodies, focusing exclusively on immunology and inflammation targets. This partnership aims to leverage the expertise of both companies in the field of immunology to address unmet medical needs.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:34 pm